Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan.

Yamashita, Yugo; Maruyama, Yuuki; Satokawa, Hirono; Nishimoto, Yuji; Tsujino, Ichizo; Sakashita, Hideki; Nakata, Hiroko; Okuno, Yoshinori; Ogihara, Yoshito; Yachi, Sen; Toya, Naoki; Shingaki, Masami; Ikeda, Satoshi; Yamamoto, Naoto; Aikawa, Shizu; Ikeda, Nobutaka; Hayashi, Hiroya; Ishiguro, Shingo; Iwata, Eriko; Umetsu, Michihisa; Kondo, Akane; Iwai, Takehisa; Kobayashi, Takao; Mo, Makoto; Yamada, Norikazu

BACKGROUND Coronavirus disease 2019 (COVID-19) reportedly causes venous thromboembolism (VTE), but the status of this complication in Japan was unclear.Methods and Results:The VTE and COVID-19 in Japan Study is a retrospective, multicenter cohort study enrolling hospitalized patients with COVID-19 who were evaluated with contrast-enhanced computed tomography (CT) examination at 22 centers in Japan between March 2020 and October 2020. Among 1,236 patients with COVID-19, 45 (3.6%) were evaluated with contrast-enhanced CT examination. VTE events occurred in 10 patients (22.2%), and the incidence of VTE in mild, moderate, and severe COVID-19 was 0%, 11.8%, and 40.0%, respectively. COVID-19 patients with VTE showed a higher body weight (81.6 vs. 64.0 kg, P=0.005) and body mass index (26.9 vs. 23.2 kg/m2, P=0.04), and a higher proportion had a severe status for COVID-19 compared with those without. There was no significant difference in the proportion of patients alive at discharge between patients with and without VTE (80.0% vs. 88.6%, P=0.48). Among 8 pulmonary embolism (PE) patients, all were low-risk PE. CONCLUSIONS Among a relatively small number of patients undergoing contrast-enhanced CT examination in Japanese real-world clinical practice, there were no VTE patients among those with mild COVID-19, but the incidence of VTE seemed to be relatively high among severe COVID-19 patients, although all PE events were low-risk without significant effect on mortality risk.